These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4890442)

  • 61. Mycosis fungoides. Hematologic findings and terminal course.
    Cyr DP; Geokas MC; Worsley GH
    Arch Dermatol; 1966 Nov; 94(5):558-73. PubMed ID: 5335518
    [No Abstract]   [Full Text] [Related]  

  • 62. Chemotherapy of the lymphomas.
    McElwain TJ
    Semin Hematol; 1974 Jan; 11(1):59-72. PubMed ID: 4859700
    [No Abstract]   [Full Text] [Related]  

  • 63. [The use of vinblastine and vincristine in the combined therapy of tumors].
    Cardinali G; Nervi C
    Tumori; 1968; 54(5):345-51. PubMed ID: 4884251
    [No Abstract]   [Full Text] [Related]  

  • 64. [Malignant lymphoma: individualized treatment according to biological and clinical risk factors].
    Dreyling M
    Dtsch Med Wochenschr; 2011 Apr; 136(14):687-90. PubMed ID: 21448827
    [No Abstract]   [Full Text] [Related]  

  • 65. [THE CLINICAL USE OF CYCLOPHOSPHAMIDE IN MALIGNANT HEMOPATHIES. EVALUATION OF THE RESULTS].
    JAMRA M; MILDER RV; VENTURELLI E
    Rev Assoc Med Bras; 1963 Jun; 9():191-202. PubMed ID: 14096204
    [No Abstract]   [Full Text] [Related]  

  • 66. Phase II trial of piperazinedione in Hodgkin's disease, non-Hodgkin's lymphoma, and multiple myeloma: a Southwest Oncology Group study.
    Jones SE; Tucker WG; Haut A; Tranum BL; Vaughn C; Chase EM; Durie BG
    Cancer Treat Rep; 1977 Dec; 61(9):1617-21. PubMed ID: 340032
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mycosis fungoides and lymphoplasmacytoid immunocytoma in the same patient. A case report.
    Geerts ML; Hamers J; Schwarze EW; Kint A; Roels H; Lennert K
    Cancer; 1984 Nov; 54(10):2294-9. PubMed ID: 6435855
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of rubomycin C on the blood system in experimental conditions].
    Gol'dberg DI; Kraìushkina NP; Antipov IG
    Antibiotiki; 1971 Mar; 16(3):240-3. PubMed ID: 5558685
    [No Abstract]   [Full Text] [Related]  

  • 69. Vinblastine treatment of malignant lymphomas.
    Klener P; Donner L; Neuwirtová R; Ort J
    Neoplasma; 1971; 18(5):505-11. PubMed ID: 4940935
    [No Abstract]   [Full Text] [Related]  

  • 70. [Early phase II clinical trial of amrubicin hydrochloride in patients with malignant lymphoma].
    Masaoka T; Ogawa M; Inoue K; Sanpi K; Kuraishi Y; Toki H; Tamura K; Takagi T; Shibata A; Hirano M; Ezaki K; Shirakawa S; Matsuda T; Kimura I
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1857-65. PubMed ID: 11729478
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Inhibition of mitosis by vinca alkaloids in malignant systemic skin diseases].
    Goerz G; Haensch R
    Dtsch Med Wochenschr; 1969 May; 94(19):998-9 passim. PubMed ID: 4888720
    [No Abstract]   [Full Text] [Related]  

  • 72. Phase I study of a combination of azotomycin (NSC-56654) and 5-fluorouracil (NSC-19893) in malignant disease.
    Weiss AJ; Mastrangelo MJ
    Cancer Chemother Rep; 1970 Apr; 54(2):109-11. PubMed ID: 4946000
    [No Abstract]   [Full Text] [Related]  

  • 73. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
    Havemann K; Schmidt M; Malchow H; Sodomann CP
    Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
    [No Abstract]   [Full Text] [Related]  

  • 74. Lymphoma in primary chronic cold hemagglutinin disease treated with chlorambucil.
    Chaplin H
    Arch Intern Med; 1982 Nov; 142(12):2119-23. PubMed ID: 6753778
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Results with CCNU in resistant Hodgkin's and non-Hodgkin's lymphoma.
    Stolinsky DC; Solomon J; Weiner JM; Bateman JR
    Oncology; 1976; 33(5-6):271-3. PubMed ID: 800240
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Streptonigrin and related compounds. 8. Hydrolysis and Hofmann reaction of ethyl 3-cyano-4-(3,4-dimethoxyphenyl)-6-methyl-2-quinolyl-5-pyridinecarboxylate. (Studies on the synthesis of heterocyclic compounds. CXCIX.)].
    Kametani T; Ogasawara K; Kozuka A
    Yakugaku Zasshi; 1967 Oct; 87(10):1195-202. PubMed ID: 5626987
    [No Abstract]   [Full Text] [Related]  

  • 77. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 78. Preliminary clinical study of aclacinomycin A.
    Majima H
    Recent Results Cancer Res; 1980; 70():75-81. PubMed ID: 6986643
    [No Abstract]   [Full Text] [Related]  

  • 79. [Subcutaneous administration of MabThera for therapy of non-Hodgkin lymphomas frees patients and medical personnel].
    Pflege Z; 2013 Apr; 66(4):253. PubMed ID: 23634557
    [No Abstract]   [Full Text] [Related]  

  • 80. [Lymphomas and immunity].
    Kouvalainen K
    Duodecim; 1970; 86(16):886-94. PubMed ID: 4917099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.